Exelixis
EXEL
#1543
Rank
C$20.34 B
Marketcap
C$82.09
Share price
1.74%
Change (1 day)
60.07%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company